Cargando…

Defining the elusive oncogenic role of the methyltransferase TMT1B

Methyltransferases are enzymes fundamental to a wide range of normal biological activities that can become dysregulated during oncogenesis. For instance, the recent description of the methyltransferase-like (METTL) family of enzymes, has demonstrated the importance of the N(6)-adenosine-methyltransf...

Descripción completa

Detalles Bibliográficos
Autores principales: Denford, Sarah E., Wilhelm, Brian T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10339810/
https://www.ncbi.nlm.nih.gov/pubmed/37456227
http://dx.doi.org/10.3389/fonc.2023.1211540
_version_ 1785071928448385024
author Denford, Sarah E.
Wilhelm, Brian T.
author_facet Denford, Sarah E.
Wilhelm, Brian T.
author_sort Denford, Sarah E.
collection PubMed
description Methyltransferases are enzymes fundamental to a wide range of normal biological activities that can become dysregulated during oncogenesis. For instance, the recent description of the methyltransferase-like (METTL) family of enzymes, has demonstrated the importance of the N(6)-adenosine-methyltransferase (m(6)A) modification in transcripts in the context of malignant transformation. Because of their importance, numerous METTL family members have been biochemically characterized to identify their cellular substrates, however some members such as METTL7B, recently renamed TMT1B and which is the subject of this review, remain enigmatic. First identified in the stacked Golgi, TMT1B is also localized to the endoplasmic reticulum as well as lipid droplets and has been reported as being upregulated in a wide range of cancer types including lung cancer, gliomas, and leukemia. Interestingly, despite evidence that TMT1B might act on protein substrates, it has also been shown to act on small molecule alkyl thiol substrates such as hydrogen sulfide, and its loss has been found to affect cellular proliferation and migration. Here we review the current evidence for TMT1B’s activity, localization, and potential biological role in the context of both normal and cancerous cell types.
format Online
Article
Text
id pubmed-10339810
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-103398102023-07-14 Defining the elusive oncogenic role of the methyltransferase TMT1B Denford, Sarah E. Wilhelm, Brian T. Front Oncol Oncology Methyltransferases are enzymes fundamental to a wide range of normal biological activities that can become dysregulated during oncogenesis. For instance, the recent description of the methyltransferase-like (METTL) family of enzymes, has demonstrated the importance of the N(6)-adenosine-methyltransferase (m(6)A) modification in transcripts in the context of malignant transformation. Because of their importance, numerous METTL family members have been biochemically characterized to identify their cellular substrates, however some members such as METTL7B, recently renamed TMT1B and which is the subject of this review, remain enigmatic. First identified in the stacked Golgi, TMT1B is also localized to the endoplasmic reticulum as well as lipid droplets and has been reported as being upregulated in a wide range of cancer types including lung cancer, gliomas, and leukemia. Interestingly, despite evidence that TMT1B might act on protein substrates, it has also been shown to act on small molecule alkyl thiol substrates such as hydrogen sulfide, and its loss has been found to affect cellular proliferation and migration. Here we review the current evidence for TMT1B’s activity, localization, and potential biological role in the context of both normal and cancerous cell types. Frontiers Media S.A. 2023-06-29 /pmc/articles/PMC10339810/ /pubmed/37456227 http://dx.doi.org/10.3389/fonc.2023.1211540 Text en Copyright © 2023 Denford and Wilhelm https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Denford, Sarah E.
Wilhelm, Brian T.
Defining the elusive oncogenic role of the methyltransferase TMT1B
title Defining the elusive oncogenic role of the methyltransferase TMT1B
title_full Defining the elusive oncogenic role of the methyltransferase TMT1B
title_fullStr Defining the elusive oncogenic role of the methyltransferase TMT1B
title_full_unstemmed Defining the elusive oncogenic role of the methyltransferase TMT1B
title_short Defining the elusive oncogenic role of the methyltransferase TMT1B
title_sort defining the elusive oncogenic role of the methyltransferase tmt1b
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10339810/
https://www.ncbi.nlm.nih.gov/pubmed/37456227
http://dx.doi.org/10.3389/fonc.2023.1211540
work_keys_str_mv AT denfordsarahe definingtheelusiveoncogenicroleofthemethyltransferasetmt1b
AT wilhelmbriant definingtheelusiveoncogenicroleofthemethyltransferasetmt1b